期刊文献+

N-叔丁氧羰基-3-羟基-1-金刚烷基甘氨酸的合成

Synthesis of N-Boc-3-hydroxyadamantylglycine
下载PDF
导出
摘要 以金刚烷甲酸(1)为起始原料,经过酰化,取代,脱羧三步反应一锅法制得金刚烷甲基酮(2),然后氧化甲基得到1-金刚烷基乙醛酸(3),将3与盐酸羟氨反应得到1-金刚烷乙醛酸肟(4),还原4并用BOC酸酐保护氨基得到N-叔丁氧羰基-1-金刚烷基甘氨酸(5),最后经高锰酸钾氧化得到DPP-IV抑制剂沙格列汀中间体N-叔丁氧羰基-3-羟基-1-金刚烷基甘氨酸(6),总收率28%。 1-Adamantylmethylketone(2) was synthesized using 1-adamantane carboxylic acid(1) as the starting material,through acylation,substitution,decarboxylation to afford. The compounds 2 was converted into 2-(1-adamantyl)-2-oxoacetic acid(3)by oxi-dation with potassium permanganate. Compound 3 reacted with hydroxylamine hydrochloride to give the 1-adamantly-2-hydroxyimino acetic acid(4),and then reduction of oxime 4 and protection of amino with Boc2O to afford N-Boc-adamantylglycine(5),hydroxyl-ation of the adamantane ring using KMnO4 afforded dipeptidyl peptidase IV( DPP-IV) inhibitor saxagliptin intermediate N-Boc-3-hydroxyadamantylglycine(6)and the overall yield is about 28%.
出处 《化学研究与应用》 CAS CSCD 北大核心 2014年第4期527-531,共5页 Chemical Research and Application
基金 重庆市自然科学基金项目(CSTC 2006BB5286)资助
关键词 N-叔丁氧羰基-3-羟基-1-金刚烷基甘氨酸 沙格列汀 合成 N-Boc-3-hydroxyadamantylglacine saxagliptin synthesis oxime
  • 相关文献

参考文献12

  • 1Mohler M L,He Y,Wu Z,et al. Recent and emerging anti- diabetes targets E J ]. Med Res Rev. 2009,29 ( 1 ) : 125-195.
  • 2Scott A. Savage, Gregory S. Jones, Sergei. Kolotuehin, et al. Preparation of saxagliptin, a novel DPP-IV inhibitor [ J ]- OrgProcess Res Dev,2009,13:l 169-1 176.
  • 3T. C. Vu, D. B. Brzozowski, R. Fox, J. D. Godfrey, et al. Methods and compounds producing dipeptidyl peptidase IV inhibitors and intermediates thereof [ P ]. WO: 2004/ 052850 A2,2004-06-24.
  • 4Ronald L Hanson, Steven L Goldberg, David B Brzozows- ki, et al. Preparation of an amino acid intermediate for the dipeptidyl peptidase IV inhibitor, saxagliptin, using a rood- flied phenylalanine dehydrogenase [ J ]. Adv Syrah Catal, 2007,349:1 369-1378.
  • 5Politino M, Cadin MM, Skonezny PM, et al. Process for preparing dipeptidyl IV inhibitors and intermediates there- for[ P]. WO :2005106011,2005-10-11.
  • 6Eric LW, Zachary LA. Synthesis process for 2-( 3-hydroxy- 1-adamantyl ) -2-oxoacetic acid [ P ]. US: 20060063950.2006-05-23.
  • 7Mathias B, Helsinki, Reijo P. Process for the perparation of adamantane derivatives : [ P]. US : 7205432 2007434-17.
  • 8Stetter, H. ; Rausher, E. Preparation of adamantine methyl ketone[ J]. Chem Ber, 1970,103:863-$65.
  • 9Charles W. Jefford, Jean-Claude Flossier, John Boukouv- alas. Eliminative ring fission of 1,2,4-trioxan-5-ones. a new approach to a-keto acids [ J ]. J Chem Soc Chem Com- mun,1986,23:l 701-1 702.
  • 10李靖柯,周鸿睿,彭俊,冯悦,胡湘南.2-(3-羟基-1-金刚烷基)-2-乙醛酸的合成[J].中国医药工业杂志,2012,43(4):251-253. 被引量:4

二级参考文献23

  • 1Augeri D J,Robl JA,Betebenner DA. Discovery and preclinical profile of saxagliptin (BMS-477118):a highly potent,long-acting,orally active dipeptidyl peptidase Ⅳ inhibitor for the treatment of type 2 diabetes[J].Journal of Medicinal Chemistry,2005,(15):5025-5037.doi:10.1021/jm050261p.
  • 2Rosenstock J,Sankoh S,List iF. Glucose-lowering activity of the dipeptidyl peptidase-4 inhibitor saxagliptin in drug-naive patients with type 2 diabetes[J].Diabetes,Obesity and Metabolism,2008,(05):376-386.
  • 3Ronald L,Hanson SL,Goldberg DB. Preparation of an amino acid intermediate for the dipeptidyl peptidase Ⅳ inhibitor,saxagliptin,using a modified phenylalanine dehydrogenase[J].Advanced Synthesis and Catalysis,2007,(8-9):1369-1378.
  • 4Poiitino M,Cadin MM,Skonezny PM. Process for preparing dipeptidyl Ⅳ inhibitors and intermediates therefor[P].WO,2005106011,2005.
  • 5Jollie D,Godfrey J,Rita T. Novel 1,4-homo-fragmentation via an γ-laetone[J].Journal of Organic Chemistry,2006,(22):8647-8650.
  • 6Percy SM,Richard LC,Joseph AM. Synthesis and antiviral activity of metabolites of rimantadine[J].Journal of Medicinal Chemistry,1990,(07):1992-1995.
  • 7Eric LW,Zachary LA. Synthesis proeess for 2-(3-hydroxy1-adamantyl)-2-oxoacetic acid[P].US,20060063950,2006.
  • 8Berner M,Partanen R,Salakka A. Process for the perparation of adamantane derivatives[P].US,7205432,2007.
  • 9Danheiser RL. Organic Synthese[M].New York:Reinhold Publishing Corporation New York,1973.20-21.
  • 10Geluk HW,Schut J,Schlatmann J. Synthesis and antiviral properties of l-adamantylguanidne,a modified method for preparing tert-alkylguanidines[J].Journal of Medicinal Chemistry,1969,(04):712-715.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部